Wang Y, Luo C
Cell Commun Signal. 2025; 23(1):38.
PMID: 39844165
PMC: 11752969.
DOI: 10.1186/s12964-025-02051-z.
Wu M, Wu S, Chen W, Li Y
Cell Res. 2024; 34(2):101-123.
PMID: 38267638
PMC: 10837209.
DOI: 10.1038/s41422-023-00918-9.
Omata Y, Okada H, Uebe S, Izawa N, Ekici A, Sarter K
JBMR Plus. 2022; 6(7):e10631.
PMID: 35866155
PMC: 9289986.
DOI: 10.1002/jbm4.10631.
Tokunaga T, Mokuda S, Kohno H, Yukawa K, Kuranobu T, Oi K
Int J Mol Sci. 2020; 21(3).
PMID: 31991837
PMC: 7038124.
DOI: 10.3390/ijms21030800.
Omi M, Kaartinen V, Mishina Y
J Biol Chem. 2019; 294(47):17818-17836.
PMID: 31619522
PMC: 6879329.
DOI: 10.1074/jbc.RA119.009521.
MicroRNAs: Key Regulators to Understand Osteoclast Differentiation?.
Lozano C, Duroux-Richard I, Firat H, Schordan E, Apparailly F
Front Immunol. 2019; 10:375.
PMID: 30899258
PMC: 6416164.
DOI: 10.3389/fimmu.2019.00375.
Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder.
Sugatani T
Int J Mol Sci. 2018; 19(9).
PMID: 30142896
PMC: 6163495.
DOI: 10.3390/ijms19092490.
Contextual determinants of TGFβ action in development, immunity and cancer.
David C, Massague J
Nat Rev Mol Cell Biol. 2018; 19(7):419-435.
PMID: 29643418
PMC: 7457231.
DOI: 10.1038/s41580-018-0007-0.
Rescue of a cherubism bone marrow stromal culture phenotype by reducing TGFβ signaling.
Liu Y, Sharma T, Chen I, Reichenberger E, Ueki Y, Arif Y
Bone. 2018; 111:28-35.
PMID: 29530719
PMC: 5924722.
DOI: 10.1016/j.bone.2018.03.009.
Glucagon-like peptide 2 decreases osteoclasts by stimulating apoptosis dependent on nitric oxide synthase.
Lu Y, Lu D, Hu Y
Cell Prolif. 2018; 51(4):e12443.
PMID: 29457300
PMC: 6528847.
DOI: 10.1111/cpr.12443.
Construction of an miRNA-Regulated Pathway Network Reveals Candidate Biomarkers for Postmenopausal Osteoporosis.
Shao M
Comput Math Methods Med. 2017; 2017:9426280.
PMID: 29158773
PMC: 5660761.
DOI: 10.1155/2017/9426280.
Dynamics of chromatin accessibility during TGF-β-induced EMT of Ras-transformed mammary gland epithelial cells.
Arase M, Tamura Y, Kawasaki N, Isogaya K, Nakaki R, Mizutani A
Sci Rep. 2017; 7(1):1166.
PMID: 28446749
PMC: 5430828.
DOI: 10.1038/s41598-017-00973-4.
Muscle-specific downregulation of GR levels inhibits adipogenesis in porcine intramuscular adipocyte tissue.
Chu W, Wei W, Han H, Gao Y, Liu K, Tian Y
Sci Rep. 2017; 7(1):510.
PMID: 28360421
PMC: 5428816.
DOI: 10.1038/s41598-017-00615-9.
Acute transcriptional up-regulation specific to osteoblasts/osteoclasts in medaka fish immediately after exposure to microgravity.
Chatani M, Morimoto H, Takeyama K, Mantoku A, Tanigawa N, Kubota K
Sci Rep. 2016; 6:39545.
PMID: 28004797
PMC: 5177882.
DOI: 10.1038/srep39545.
Smad-dependent mechanisms of inflammatory bone destruction.
Fennen M, Pap T, Dankbar B
Arthritis Res Ther. 2016; 18(1):279.
PMID: 27906049
PMC: 5134126.
DOI: 10.1186/s13075-016-1187-7.
Smad4 is required to inhibit osteoclastogenesis and maintain bone mass.
Morita M, Yoshida S, Iwasaki R, Yasui T, Sato Y, Kobayashi T
Sci Rep. 2016; 6:35221.
PMID: 27731422
PMC: 5059689.
DOI: 10.1038/srep35221.
Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease.
Sugatani T, Agapova O, Fang Y, Berman A, Wallace J, Malluche H
Kidney Int. 2016; 91(1):86-95.
PMID: 27666759
PMC: 5530394.
DOI: 10.1016/j.kint.2016.07.039.
GDF11 decreases bone mass by stimulating osteoclastogenesis and inhibiting osteoblast differentiation.
Liu W, Zhou L, Zhou C, Zhang S, Jing J, Xie L
Nat Commun. 2016; 7:12794.
PMID: 27653144
PMC: 5036163.
DOI: 10.1038/ncomms12794.
Osteoclasts-Key Players in Skeletal Health and Disease.
Novack D, Mbalaviele G
Microbiol Spectr. 2016; 4(3).
PMID: 27337470
PMC: 4920143.
DOI: 10.1128/microbiolspec.MCHD-0011-2015.
Identification of Nedd9 as a TGF-β-Smad2/3 Target Gene Involved in RANKL-Induced Osteoclastogenesis by Comprehensive Analysis.
Omata Y, Nakamura S, Koyama T, Yasui T, Hirose J, Izawa N
PLoS One. 2016; 11(6):e0157992.
PMID: 27336669
PMC: 4918979.
DOI: 10.1371/journal.pone.0157992.